Lining fluid flow and surfactant transport during the unsteady opening of pulmonary airways and alveoli

出生时，新生儿的肺部充满液体，必须从折叠状态充气才能开始呼吸。对于健康的婴儿来说，适度的吸气努力将空气引入肺部，这样大气就可以直接与肺泡沟通，肺泡是与血液进行气体交换的主要部位。胎盘成熟的肺会释放表面活性物质，从而减少充气所需的努力。然而，早产儿可能缺乏足够的表面活性物质，从而增加表面张力。肺表面活性物质不足，加上肺体积极小，导致早产肺膨胀所需的大量吸气力，导致呼吸道不张(肺部分广泛塌陷)，肺机械反应紊乱，通风/灌流关系差，肺泡通气量不足。这些早熟的呼吸道可以通过机械呼吸机的高压打开，但这会破坏排列在气道壁上的敏感上皮细胞，导致呼吸窘迫综合征(RDS)。肺表面活性物质替代疗法(SRT)始于20世纪80年代末的S，极大地减少了与本病相关的死亡人数。改善外源性表面活性物质成分继续改善RDS婴儿的结局。然而，RDS仍然是美国早产儿死亡的第四大原因。这项拟议的研究的目标是开发与表面活性物质物理化学相互作用相耦合的肺机械行为的综合模型。我们打算利用我们对表面活性物质的物理化学性质和流体-结构相互作用的理解来确定可能保护肺免受RDS影响的表面活性物质的性质。此外，我们将尝试利用表面活性物质吸附和解吸速率之间的巨大差异以及表面活性物质多层的创建来指定通风参数，这些参数将积极地提高表面活性物质浓度，从而优化肺通道的开放。我们预计，这些模型将使我们能够预测表面活性物质的性质和通风情景，这将有助于改善患有RDS的婴儿的预后。

9978605GaverAt birth, a newborn infant's lungs are liquid-filled and must be inflated from a collapsed state to initiate breathing. For healthy infants, a modest inspiratory effort introduces air into the lung so that the atmosphere can directly communicate with alveoli, the primary site of gas-exchange with blood. Gestationally mature lungs release surfactant that decreases the effort necessary to inflate the lung. However, premature infants may lack adequate surfactant, increasing the surface tension. Surfactant insufficiency coupled with the extremely small size of the lung results in a large inspiratory effort necessary to inflate the premature lung, leading to airway atelectasis (extensive collapse of portions of the lung), deranged pulmonary mechanical responses, poor ventilation/perfusion relationships and insufficient alveolar ventilation. These premature airways could be opened by high pressure from a mechanical ventilator, however this damages the sensitive epithelial cells that line the airway walls, resulting in respiratory distress syndrome (RDS). Surfactant replacement therapy (SRT), initiated in the late 1980's, has dramatically reduced the number of fatalities associated with this disease. Refinements in exogenous surfactant composition continue to improve the outcome of RDS infants. Nevertheless, RDS remains the fourth leading cause of death of premature infants in the United States.The goal of the proposed research is to develop integrated models of pulmonary mechanical behavior coupled to surfactant physicochemical interactions. We intend to take advantage of our understanding of surfactant physicochemical properties and fluid-structure interactions to identify surfactant properties that may protect the lung from RDS. Additionally, we will attempt to use the large disparity between surfactant adsorption and desorption rates and the creation of surfactant multi-layers to specify ventilation parameters that will actively enhance surfactant concentration and thus optimize the opening of pulmonary airways. We anticipate that these models will allow us to predict surfactant properties and ventilation scenarios that will be useful in improving the outcome of infants afflicted with RDS.